No registrations found.
ID
Source
Brief title
Health condition
Colorectal cancer, colorectal serrated polyps
Sponsors and support
Intervention
Outcome measures
Primary outcome
association between PSPDR and PCCRC (interval type and detected at screening type)
Secondary outcome
association of PSPDR and PCCRC with other colonoscopy qualitiy indicators
Background summary
Colonoscopy is the best method for the detection and thus preventing colorectal cancer. Nevertheless, CRC also occurs in patients who have received a complete colonoscopy in which all detected polyps were removed followed by an interval adjusted surveillance colonoscopy. Such cases of CRC are referred to as post-colonoscopy CRCs (PCCRCs). In 2010, Kaminski et al showed the importance of the adenoma detection rate (ADR) as a quality parameter for colonoscopy to be strongly associated with the 5-year incidence of PCCRC.
Over the last decades, however, there has been a great paradigm shift in the theories of the CRC development. It is now clear that not only conventional adenomas are precursor lesions of CRC but also serrated polyps (SPs) are accounting for up to 30% of the CRCs in total. Moreover, there are different findings that suggest that the serrated neoplasia pathway is represented in the development of PCCRC. That would suggest that endoscopist with a higher detection rate of SPs miss fewer SPs and have a lower risk of developing PCCRC.
Study objective
By increasing endoscopist's proximal serrated polyp detection rate (PSPDR) it will lower the incidence of postcolonoscopy colorectal carcinoma (PCCRC).
Study design
N/A
Intervention
N/A
Inclusion criteria
All FIT-positive colonoscopies within the Dutch screening program for colorectal cancer.
Exclusion criteria
None
Design
Recruitment
IPD sharing statement
Plan description
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL8350 |
Other | METC AMC : W20_021#20.046 (decision: non-WMO; no formal ethical approval required) |